학술논문
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227.
Document Type
Article
Author
Brahmer, Julie R.; Lee, Jong-Seok; Ciuleanu, Tudor-Eliade; Bernabe Caro, Reyes; Nishio, Makoto; Urban, Laszlo; Audigier-Valette, Clarisse; Lupinacci, Lorena; Sangha, Randeep; Pluzanski, Adam; Burgers, Jacobus; Mahave, Mauricio; Ahmed, Samreen; Schoenfeld, Adam J.; Paz-Ares, Luis G.; Reck, Martin; Borghaei, Hossein; O'Byrne, Kenneth J.; Gupta, Ravi G.; Bushong, Judith
Source
Journal of Clinical Oncology; 2/20/2023, Vol. 41 Issue 6, p1200-1212, 13p
Subject
Language
ISSN
0732183X